论文部分内容阅读
目的评价纳洛酮治疗小儿急性中枢性呼吸衰竭的临床疗效。方法选择我院2012年9月至2013年9月收治的80例小儿急性中枢性呼吸衰竭患儿,将其随机分为两组,对照组采用常规基础治疗,观察组在常规治疗的基础上给予纳洛酮,对比两组患儿临床治疗效果。结果治疗后,观察组患儿的治疗有效率明显高于对照组(P<0.05)。观察组患儿临床症状改善情况、血气改善情况明显优于对照组,差异具有统计学意义,P<0.05。结论临床给予纳洛酮治疗小儿急性中枢性呼吸衰竭效果显著,患儿临床症状与血气均显著改善。
Objective To evaluate the clinical efficacy of naloxone in the treatment of pediatric acute central respiratory failure. Methods Eighty children with acute central respiratory failure admitted to our hospital from September 2012 to September 2013 were randomly divided into two groups. The control group received routine basic treatment. The observation group was given conventional treatment Naloxone, compared with two groups of children with clinical treatment. Results After treatment, the treatment efficiency in observation group was significantly higher than that in control group (P <0.05). Clinical symptoms of children in observation group to improve the situation, improvement of blood gas was significantly better than the control group, the difference was statistically significant, P <0.05. Conclusion The clinical efficacy of naloxone in treating children with acute central respiratory failure is remarkable. The clinical symptoms and blood gas of children are significantly improved.